Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) just unveiled an announcement.
ResMed Inc. has filed a notice for the proposed sale of securities under Rule 144, with Michael Farrell, an officer and director of the company, planning to sell 8,009 shares of common stock. The aggregate market value of these shares is approximately $2,265,185.47, and the sale is scheduled for August 7, 2025. This transaction follows previous sales by Farrell in May and June 2025, indicating a strategic move in managing personal investments, which may have implications for stakeholders regarding insider confidence and market perception.
The most recent analyst rating on (AU:RMD) stock is a Buy with a A$41.00 price target. To see the full list of analyst forecasts on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh stock, see the AU:RMD Stock Forecast page.
More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
ResMed Inc. operates in the healthcare industry, focusing on the development and manufacturing of products for the treatment of sleep disorders, respiratory care, and related medical conditions. The company is known for its innovative solutions in sleep apnea therapy and other respiratory care products, catering to a global market.
Average Trading Volume: 869,315
Technical Sentiment Signal: Buy
Current Market Cap: A$64.19B
See more insights into RMD stock on TipRanks’ Stock Analysis page.